Alcohol Use Disorder Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX TH

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Alcohol Use Disorder pipeline constitutes 30+ key companies continuously working towards developing 30+ Alcohol Use Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Alcohol Use Disorder Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Alcohol Use Disorder Market.

The Alcohol Use Disorder Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Alcohol Use Disorder Pipeline Report: https://www.delveinsight.com/sample-request/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Alcohol Use Disorder treatment therapies with a considerable amount of success over the years. Alcohol Use Disorder Key players such as - Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others, are developing therapies for the Alcohol Use Disorder treatment
• Alcohol Use Disorder Emerging therapies such as - Pear-009, CYB003, Nezavist, BXCL501, PT150, DCR-AUD, ASP8062, KT 110, Ibudilast, AD04, and others are expected to have a significant impact on the Alcohol Use Disorder market in the coming years.
• In April 2022, MediciNova, Inc. disclosed that a supplementary examination of a Phase II clinical study investigating MN-166 (ibudilast) in alcohol use disorder (AUD) has been published in Alcoholism: Clinical and Experimental Research journal.
• In January 2022, Adial Pharmaceuticals revealed that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for US Patent Application No. 16/784,051, pertaining to the treatment of opioid use disorder (OUD) using AD04. This patent application encompasses the treatment of individuals with a distinct genetic biomarker associated with the serotonin-3 receptor.

Alcohol Use Disorder Overview
Alcohol use disorder (AUD) is a chronic and relapsing condition characterized by an inability to control or limit alcohol consumption despite its negative consequences on physical health, mental well-being, and social functioning. It is considered a spectrum disorder, with varying degrees of severity ranging from mild to severe.

Get a Free Sample PDF Report to know more about Alcohol Use Disorder Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Route of Administration
Alcohol Use Disorder pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Infusion
• Intradermal
• Intramuscular
• Intranasal
• Intravenous
• Oral
• Parenteral
• Subcutaneous
• Topical
• Molecule Type

Molecule Type
Products have been categorized under various Molecule types, such as
• Gene therapies
• Small molecule
• Vaccines
• Polymers
• Peptides
• Monoclonal antibodies
• Product Type

Alcohol Use Disorder Pipeline Therapeutics Assessment
• Alcohol Use Disorder Assessment by Product Type
• Alcohol Use Disorder By Stage and Product Type
• Alcohol Use Disorder Assessment by Route of Administration
• Alcohol Use Disorder By Stage and Route of Administration
• Alcohol Use Disorder Assessment by Molecule Type
• Alcohol Use Disorder by Stage and Molecule Type

DelveInsight's Alcohol Use Disorder Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Alcohol Use Disorder product details are provided in the report. Download the Alcohol Use Disorder pipeline report to learn more about the emerging Alcohol Use Disorder therapies
https://www.delveinsight.com/sample-request/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Alcohol Use Disorder Therapeutics Market include:
Key companies developing therapies for Alcohol Use Disorder are - Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX THERAPEUTICS, Kinnov Therapeutics, Opiant Pharmaceuticals, Ethypharm, Omeros Corporation, Montisera Ltd., and others

Emerging Alcohol Use Disorder Drugs Under Different Phases of Clinical Development Include:
• Pear-009: Pear Therapeutics
• CYB003: Cybin
• Nezavist: Lohocla Research
• BXCL501: BioXcel Therapeutics
• PT150: Pop Test Oncology
• DCR-AUD: Dicerna Pharmaceuticals
• ASP8062: Astellas Pharma
• KT 110: Kinnov Therapeutics
• Ibudilast: MediciNova
• AD04 : Adial Pharmaceuticals

Alcohol Use Disorder Pipeline Analysis:
The Alcohol Use Disorder pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Alcohol Use Disorder with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Alcohol Use Disorder Treatment.
• Alcohol Use Disorder key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Alcohol Use Disorder Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Alcohol Use Disorder market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Alcohol Use Disorder drugs and therapies
https://www.delveinsight.com/sample-request/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Alcohol Use Disorder Pipeline Market Drivers
• Increasing Awareness
• Increasing research and development
• Initiative taken by market players

Alcohol Use Disorder Pipeline Market Barriers
• Less Treatment Utilization
• Side Effects of The Current Therapies

Scope of Alcohol Use Disorder Pipeline Drug Insight
• Coverage: Global
• Key Alcohol Use Disorder Companies: Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others
• Key Alcohol Use Disorder Therapies: Pear-009, CYB003, Nezavist, BXCL501, PT150, DCR-AUD, ASP8062, KT 110, Ibudilast, AD04, and others
• Alcohol Use Disorder Therapeutic Assessment: Alcohol Use Disorder current marketed and Alcohol Use Disorder emerging therapies
• Alcohol Use Disorder Market Dynamics: Alcohol Use Disorder market drivers and Alcohol Use Disorder market barriers

Request for Sample PDF Report for Alcohol Use Disorder Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Alcohol Use Disorder Report Introduction
2 Alcohol Use Disorder Executive Summary
3 Alcohol Use Disorder Overview
4 Alcohol Use Disorder- Analytical Perspective In-depth Commercial Assessment
5 Alcohol Use Disorder Pipeline Therapeutics
6 Alcohol Use Disorder Late Stage Products (Phase II/III)
7 Alcohol Use Disorder Mid Stage Products (Phase II)
8 Alcohol Use Disorder Early Stage Products (Phase I)
9 Alcohol Use Disorder Preclinical Stage Products
10 Alcohol Use Disorder Therapeutics Assessment
11 Alcohol Use Disorder Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Alcohol Use Disorder Key Companies
14 Alcohol Use Disorder Key Products
15 Alcohol Use Disorder Unmet Needs
16 Alcohol Use Disorder Market Drivers and Barriers
17 Alcohol Use Disorder Future Perspectives and Conclusion
18 Alcohol Use Disorder Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Related Reports:

Alcohol Use Disorder Market https://www.delveinsight.com/report-store/alcohol-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Alcohol Use Disorder-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Alcohol Use Disorder Epidemiology https://www.delveinsight.com/report-store/alcohol-use-disorder-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Alcohol Use Disorder Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Iga Nephropathy Market
https://www.delveinsight.com/report-store/iga-nephropathy-market
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Japan, and China.

Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
DelveInsight's "Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Gastroesophageal Reflux Disease Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastroesophageal Reflux Disease (GERD), historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease (GERD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.